All News
Filter News
Found 808,690 articles
-
Intrexon Announces Second Quarter Financial Results
9/20/2013
-
John Wiley & Sons, Inc. Declares Quarterly Dividend
9/20/2013
-
Pro-Dex, Inc. Announces Fiscal 2013 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
9/20/2013
-
Tenex Health Chief Financial Officer to Resign on September 30, 2013
9/20/2013
-
Kythera Biopharmaceuticals Appoints F. Michael Ball to Board of Directors
9/20/2013
-
Perrigo Company Appoints FDA Veteran as New Head of Regulatory Review
9/20/2013
-
Vital Therapies, Inc. (VTI) Expands Board of Directors
9/20/2013
-
BioAlberta Release: Alberta Life Sciences Report Highlights Continued Industry Growth and an Upbeat Outlook
9/20/2013
-
GHX Encourages Healthcare Manufacturers to Take a Holistic, Strategic Approach to UDI in the Wake of the U.S. FDA’s Final Ruling
9/20/2013
-
Covidien plc Launches Response Effort in Support of Colorado Flood Relief
9/20/2013
-
Sequenta, Inc. Develops Novel Method for Identifying Antigen-Specific T Cells by Combining Conventional Immune Monitoring Assays With High-Throughput Repertoire Sequencing
9/20/2013
-
Young Scientists Receive National Space Biomedical Research Institute (NSBRI) Space Biomedical Research Fellowships
9/20/2013
-
Governor Patrick and the Massachusetts Life Sciences Center Celebrate Growth in the Massachusetts Biopharma Industry
9/20/2013
-
AxoGen, Inc. Release: Significant U.S. Peripheral Nerve Repair Market Opportunity Highlighted in New Independent Research
9/20/2013
-
BCC Research Publishes a New Report on Global Markets for Cervical Cancer Drugs and Diagnostics
9/20/2013
-
Corporate Directors Forum Names NuVasive, Inc. Board Member as Director of the Year
9/20/2013
-
Frost & Sullivan Recognizes LI-COR Biosciences for Developing NIR Fluorescence, Contributing to Advancing Preclincal Industry
9/20/2013
-
BioIndustry Association: Two UK Companies Shortlisted for EuropaBio Most Innovative EU Biotech SME Award
9/20/2013
-
BioSpecifics Technologies Corporation to Present at the Aegis Capital 2013 Healthcare Conference
9/20/2013
-
Zealand Pharma Informs of New Scientific Presentations on Lyxumia® (lixisenatide) and on Proprietary GLP-1-Gastrin Dual Agonist at the EASD 49th Annual Meeting
9/20/2013